全文阅读
本文对１０例早期急性心肌梗塞（ＡＭＩ）病人，用太原生物化学制药厂产尿激酶（ＵＫ）／２万ｕ／ｋｇ，３０ｍｉｎ内滴完进行静脉内溶栓治疗，以２项或２项以上指标制定冠脉再通。结果６例再通，其中有２例未发生坏死性Ｑ波。认为ＡＭＩ在１２ｈ内无溶栓禁忌症时均应进行静脉溶栓；并认为用ＵＫ进行静脉溶栓安全有效，简便易行，适用于各级医院抢救ＡＭＩ患者，更适用于基层医院。
In this paper, 10 cases of patients with early acute myocardial infarction (AMI) were treated with intravenous thrombolysis by intravenous thrombolysis in 30 days with urokinase (UK) / 20,000 u / kg in Taiyuan Biochemical Pharmaceutical Factory, with 2 or more Indicators of coronary recanalization. Results 6 cases recanalization, of which 2 cases did not occur necrotizing Q wave. It is considered that intravenous thrombolysis should be carried out when AMI has no thrombolytic contraindications in 12h. It is safe and effective to administer intravenous thrombolysis with UK, which is suitable for emergency treatment of patients with AMI at all levels and more suitable for primary hospitals.